data_2mpv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mpv _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.679 0.276 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.31 53.8 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.358 0.599 . . . . 0.0 112.22 -176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 61.1 m -131.57 132.13 43.86 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.46 173.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -131.88 128.0 37.69 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 120.982 0.42 . . . . 0.0 110.466 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 1.2 mp -136.69 126.85 39.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 m -162.53 139.65 8.0 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.522 0.677 . . . . 0.0 112.139 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.717 ' HA ' ' O ' ' A' ' 40' ' ' THR . 6.4 mt -113.89 109.14 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.238 170.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.496 ' HB ' ' CD ' ' A' ' 21' ' ' PRO . 20.6 p -74.81 166.0 49.09 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -153.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' CD ' ' HB ' ' A' ' 20' ' ' THR . 47.7 Cg_exo -58.77 -12.92 16.05 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 125.174 3.916 . . . . 0.0 116.579 -167.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.26 -6.97 11.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.822 0.737 . . . . 0.0 110.437 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.701 ' HB ' ' OG ' ' A' ' 152' ' ' SER . 0.6 OUTLIER -62.53 140.1 58.62 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.889 171.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.448 ' N ' ' HB3' ' A' ' 152' ' ' SER . 3.5 t30 71.08 150.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.746 176.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.605 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 4.1 mmp_? -112.87 -174.79 2.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.519 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.08 -110.22 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.62 -172.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.2 t -90.58 -58.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.134 0.492 . . . . 0.0 110.301 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -168.53 151.95 5.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.816 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.89 134.43 60.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.294 0.569 . . . . 0.0 110.971 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' HB3' HG23 ' A' ' 157' ' ' VAL . 8.1 p-10 -124.39 27.42 7.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.681 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.414 ' HG3' HD13 ' A' ' 35' ' ' ILE . 9.2 ptp180 -103.49 131.72 50.36 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.148 -176.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 p -98.4 88.47 4.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 166.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.415 ' C ' ' HD3' ' A' ' 117' ' ' PRO . . . -159.69 173.29 16.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.008 -174.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -71.36 111.5 6.73 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.695 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.472 ' HB ' ' CG2' ' A' ' 115' ' ' ILE . 4.3 mt -115.51 87.32 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -75.19 126.27 30.68 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.772 0.796 . . . . 0.0 110.605 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.1 mt -123.92 108.9 12.93 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.372 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 16.4 m -99.15 109.68 22.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.24 0.543 . . . . 0.0 111.139 -174.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.456 ' HB3' ' CD1' ' A' ' 130' ' ' LEU . 75.7 m-85 -101.25 159.94 14.83 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.717 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 96.1 m -148.7 144.18 26.95 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.143 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.89 124.2 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 17' ' ' ILE . 59.4 mtp180 -111.92 145.99 38.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' HG3' ' HD2' ' A' ' 44' ' ' PRO . 2.3 mp0 -123.62 167.47 14.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.427 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 19.8 Cg_endo -55.44 123.31 13.5 Favored 'Trans proline' 0 N--CA 1.472 0.219 0 C-N-CA 123.75 2.967 . . . . 0.0 114.033 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.673 ' HG2' ' CE2' ' A' ' 107' ' ' TYR . 18.6 mt-30 -62.39 -46.94 86.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.067 177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -76.7 -32.13 57.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.332 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 m -73.3 -40.35 64.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.37 84.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.14 0.495 . . . . 0.0 109.789 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -73.58 -10.6 59.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.108 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.97 -8.5 54.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.975 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.19 16.36 11.37 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.305 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 11.9 mmt -105.78 151.12 24.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -98.14 156.62 16.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.298 0.57 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.11 139.16 18.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.491 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.59 ' HD2' ' CZ3' ' A' ' 57' ' ' TRP . 28.3 ttmt -118.36 130.39 55.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.794 175.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.02 140.51 24.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.723 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.59 ' CZ3' ' HD2' ' A' ' 55' ' ' LYS . 6.6 p90 -158.86 161.39 36.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.913 0.387 . . . . 0.0 110.645 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.5 -133.16 3.22 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.265 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 19.1 tt0 -130.46 7.03 4.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -171.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . . . -62.4 177.25 0.52 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 121.332 -0.147 . . . . 0.0 111.137 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -56.98 -30.81 64.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.173 0.511 . . . . 0.0 110.078 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -100.48 12.05 38.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.471 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.52 43.44 77.21 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -108.63 -40.04 5.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -173.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' A' ' 111' ' ' MET . 65.8 tp 165.57 126.98 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 59' ' ' GLU . 46.1 tp -152.15 143.27 23.18 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.832 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 tt -106.22 111.42 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.946 0.879 . . . . 0.0 109.43 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.06 143.55 44.55 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.863 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -47.25 133.45 19.44 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 124.33 3.353 . . . . 0.0 113.203 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -58.46 123.05 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.343 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.39 -0.94 87.33 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.901 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.12 -176.79 31.84 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.553 -0.356 . . . . 0.0 112.236 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -103.5 143.5 32.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.112 0.482 . . . . 0.0 110.492 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -27.13 67.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.663 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.2 m -74.01 -12.81 60.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.933 0.397 . . . . 0.0 110.793 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.93 -5.39 19.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.257 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.08 173.91 34.61 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.093 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CD1' HG13 ' A' ' 119' ' ' ILE . 18.7 m-85 -108.38 130.09 55.23 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.7 p -67.56 150.89 48.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.132 0.492 . . . . 0.0 111.861 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.456 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 4.4 mm? -81.61 36.44 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.106 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.39 -87.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.53 0.732 . . . . 0.0 112.238 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.2 p -138.11 83.12 23.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.942 0.401 . . . . 0.0 110.023 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HB3' ' SD ' ' A' ' 111' ' ' MET . 52.3 Cg_exo -57.58 130.33 38.29 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.115 2.544 . . . . 0.0 112.875 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -113.45 149.94 33.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.791 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 110' ' ' GLY . 60.3 m-85 -121.85 111.61 17.32 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.405 0.441 . . . . 0.0 110.359 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -103.33 157.12 17.24 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.461 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -162.19 -176.41 5.12 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.752 -177.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.447 ' HB ' HG12 ' A' ' 106' ' ' VAL . 19.1 mm -86.68 106.47 10.65 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 87' ' ' TYR . 24.9 Cg_exo -63.23 118.48 5.39 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.337 2.024 . . . . 0.0 112.064 -176.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -177.51 -69.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.123 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 93.6 m-20 -135.54 98.73 12.12 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.523 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -88.2 179.47 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.223 2.615 . . . . 0.0 112.68 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 101' ' ' LEU . . . -156.08 173.86 16.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.386 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -85.93 149.6 25.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.688 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.4 mt -75.58 95.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.947 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 92.1 mtp -141.43 -177.32 5.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.199 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 69.66 7.51 6.27 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.75 10.9 58.52 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.768 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.524 ' CD1' ' HG3' ' A' ' 55' ' ' LYS . 26.5 p90 -159.34 -175.66 5.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 0.0 111.138 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.78 130.93 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.543 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -145.6 151.96 38.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.305 -178.008 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.422 ' OG1' ' HB ' ' A' ' 106' ' ' VAL . 44.7 p -110.88 -175.2 2.65 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 176.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 3.8 m-20 -89.91 164.98 26.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.69 139.72 83.55 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.187 1.924 . . . . 0.0 112.042 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.94 -12.72 31.98 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.447 HG12 ' HB ' ' A' ' 88' ' ' ILE . 94.7 t -123.93 135.86 62.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.603 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.673 ' CE2' ' HG2' ' A' ' 45' ' ' GLN . 9.7 p90 -142.11 83.75 1.85 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 173.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -167.18 134.66 2.44 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.652 -0.655 . . . . 0.0 110.298 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -144.14 109.0 4.94 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 165.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 85' ' ' PHE . . . -101.76 105.88 2.92 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.566 ' HB3' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -105.53 102.88 12.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 9.8 pt20 -112.06 121.46 45.04 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.44 0.638 . . . . 0.0 110.733 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 80' ' ' LEU . . . -115.62 -178.5 18.47 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.37 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.8 t -145.48 119.5 9.39 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.472 ' CG2' ' HB ' ' A' ' 35' ' ' ILE . 6.1 tt -75.55 110.38 10.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 165.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 117' ' ' PRO . 14.1 p -111.59 169.87 5.87 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.829 -168.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 116' ' ' THR . 17.9 Cg_endo -60.5 -2.06 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.164 2.576 . . . . 0.0 112.832 175.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.9 -20.32 66.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.749 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.515 HG13 ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -122.46 123.65 27.0 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.099 174.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.68 122.9 9.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.396 1.398 . . . . 0.0 110.848 174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.537 ' HB2' ' CG2' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -75.52 144.48 41.94 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.45 -176.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.65 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 55.4 ttp180 172.47 -42.85 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.716 -173.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 10.8 Cg_endo -54.77 164.81 2.95 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.5 2.133 . . . . 0.0 112.806 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.83 -160.03 16.35 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.059 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.491 ' HB3' ' CG2' ' A' ' 153' ' ' THR . 45.7 mt -58.92 144.39 44.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.819 0.342 . . . . 0.0 111.713 -169.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.753 ' CZ ' HG13 ' A' ' 156' ' ' VAL . 23.0 m-85 -99.8 161.34 13.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.471 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -128.76 128.33 43.79 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 151' ' ' THR . 22.2 m -121.49 120.26 61.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.986 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 14.5 p -119.61 134.24 63.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.248 0.547 . . . . 0.0 111.272 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 39' ' ' PHE . 10.0 mt -122.67 140.57 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.089 171.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.516 ' ND2' HG22 ' A' ' 149' ' ' THR . 13.9 m120 -122.54 148.64 44.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.973 -175.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 147' ' ' ALA . . . -132.85 144.92 50.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.242 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.94 151.09 21.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 110.81 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.73 129.39 51.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.557 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.48 179.9 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.843 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 25.7 m 79.43 -48.69 0.39 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.521 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -66.23 -52.72 45.02 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.36 -73.61 0.21 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.143 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -149.21 155.43 40.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -119.71 74.59 1.02 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -121.12 -74.42 0.61 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -150.23 -56.94 0.18 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.546 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.549 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . . . -134.1 131.68 39.02 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.5 t -159.24 -42.87 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -174.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.09 -146.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.8 t -79.85 113.96 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.567 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 132' ' ' ALA . . . -96.29 119.27 34.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.321 0.582 . . . . 0.0 110.076 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 131' ' ' ASN . 16.4 ttmm -95.0 155.12 16.86 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.07 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.516 HG22 ' ND2' ' A' ' 131' ' ' ASN . 12.1 p -136.97 137.91 40.0 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 120.897 0.38 . . . . 0.0 111.983 -175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 129' ' ' VAL . . . -146.51 121.67 10.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.81 170.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 128' ' ' VAL . 28.2 m -124.09 135.07 53.29 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.489 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.701 ' OG ' ' HB ' ' A' ' 23' ' ' THR . 4.1 m -130.42 135.82 48.4 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.69 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 3.8 m -94.91 125.59 39.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.357 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.82 124.28 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.43 ' HA ' ' CD2' ' A' ' 125' ' ' LEU . 10.0 m -88.31 105.53 17.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.306 0.574 . . . . 0.0 111.67 -175.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.753 HG13 ' CZ ' ' A' ' 126' ' ' TYR . 5.8 p -108.26 129.69 62.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.877 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 30' ' ' ASP . 15.9 m . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.17 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.679 0.276 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.31 53.8 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.358 0.599 . . . . 0.0 112.22 -176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 61.1 m -131.57 132.13 43.86 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.46 173.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -131.88 128.0 37.69 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 120.982 0.42 . . . . 0.0 110.466 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 1.2 mp -136.69 126.85 39.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 m -162.53 139.65 8.0 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.522 0.677 . . . . 0.0 112.139 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.745 ' HA ' ' O ' ' A' ' 40' ' ' THR . 6.4 mt -113.89 109.14 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.238 170.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.493 ' HB ' ' CD ' ' A' ' 21' ' ' PRO . 20.6 p -74.81 166.0 49.09 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -153.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.493 ' CD ' ' HB ' ' A' ' 20' ' ' THR . 47.7 Cg_exo -58.77 -12.92 16.05 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 125.174 3.916 . . . . 0.0 116.579 -167.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.26 -6.97 11.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.822 0.737 . . . . 0.0 110.437 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.712 ' HB ' ' OG ' ' A' ' 152' ' ' SER . 0.6 OUTLIER -62.53 140.1 58.62 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.889 171.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' N ' ' HB3' ' A' ' 152' ' ' SER . 3.5 t30 71.08 150.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.746 176.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 4.1 mmp_? -112.87 -174.79 2.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.519 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.08 -110.22 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.62 -172.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.2 t -90.58 -58.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.134 0.492 . . . . 0.0 110.301 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -168.53 151.95 5.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.816 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.89 134.43 60.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.294 0.569 . . . . 0.0 110.971 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 157' ' ' VAL . 8.1 p-10 -124.39 27.42 7.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.681 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HG3' HD11 ' A' ' 35' ' ' ILE . 9.2 ptp180 -103.49 131.72 50.36 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.148 -176.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 p -98.4 88.47 4.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 166.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.435 ' C ' ' HD3' ' A' ' 117' ' ' PRO . . . -159.69 173.29 16.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.008 -174.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -71.36 111.5 6.73 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.695 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.565 ' HB ' HG23 ' A' ' 115' ' ' ILE . 4.3 mt -115.51 87.32 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -75.19 126.27 30.68 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.772 0.796 . . . . 0.0 110.605 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.1 mt -123.92 108.9 12.93 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.372 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 16.4 m -99.15 109.68 22.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.24 0.543 . . . . 0.0 111.139 -174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB3' HD12 ' A' ' 130' ' ' LEU . 75.7 m-85 -101.25 159.94 14.83 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.745 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 96.1 m -148.7 144.18 26.95 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.143 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD13 HD12 ' A' ' 109' ' ' LEU . 3.6 mp -123.89 124.2 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' ILE . 59.4 mtp180 -111.92 145.99 38.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.575 HE22 ' HB1' ' A' ' 132' ' ' ALA . 2.3 mp0 -123.62 167.47 14.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.427 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' HG3' ' A' ' 43' ' ' GLN . 19.8 Cg_endo -55.44 123.31 13.5 Favored 'Trans proline' 0 N--CA 1.472 0.219 0 C-N-CA 123.75 2.967 . . . . 0.0 114.033 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.673 ' HG2' ' CE2' ' A' ' 107' ' ' TYR . 18.6 mt-30 -62.39 -46.94 86.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.067 177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -76.7 -32.13 57.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.332 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 44' ' ' PRO . 18.9 m -73.3 -40.35 64.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.37 84.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.14 0.495 . . . . 0.0 109.789 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -73.58 -10.6 59.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.108 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.97 -8.5 54.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.975 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.19 16.36 11.37 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.305 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 11.9 mmt -105.78 151.12 24.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.441 ' HD3' HD23 ' A' ' 101' ' ' LEU . 59.4 mtt180 -98.14 156.62 16.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.298 0.57 . . . . 0.0 111.17 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.11 139.16 18.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.491 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.611 ' HD2' ' CZ3' ' A' ' 57' ' ' TRP . 28.3 ttmt -118.36 130.39 55.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.794 175.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.02 140.51 24.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.723 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.611 ' CZ3' ' HD2' ' A' ' 55' ' ' LYS . 6.6 p90 -158.86 161.39 36.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.913 0.387 . . . . 0.0 110.645 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.5 -133.16 3.22 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.265 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 19.1 tt0 -130.46 7.03 4.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -171.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.58 ' HB3' ' H ' ' A' ' 64' ' ' GLN . . . -62.4 177.25 0.52 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 121.332 -0.147 . . . . 0.0 111.137 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -56.98 -30.81 64.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.173 0.511 . . . . 0.0 110.078 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -100.48 12.05 38.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.471 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.52 43.44 77.21 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.58 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 20.3 mm-40 -108.63 -40.04 5.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.578 HD22 ' HB3' ' A' ' 111' ' ' MET . 65.8 tp 165.57 126.98 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 46.1 tp -152.15 143.27 23.18 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.832 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.402 ' O ' HG23 ' A' ' 67' ' ' ILE . 16.7 tt -106.22 111.42 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.946 0.879 . . . . 0.0 109.43 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.06 143.55 44.55 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.863 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -47.25 133.45 19.44 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 124.33 3.353 . . . . 0.0 113.203 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -58.46 123.05 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.343 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.39 -0.94 87.33 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.901 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.12 -176.79 31.84 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.553 -0.356 . . . . 0.0 112.236 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -103.5 143.5 32.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.112 0.482 . . . . 0.0 110.492 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -60.28 -27.13 67.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.663 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.2 m -74.01 -12.81 60.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.933 0.397 . . . . 0.0 110.793 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.93 -5.39 19.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.257 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.08 173.91 34.61 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.093 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.517 ' CD1' HG13 ' A' ' 119' ' ' ILE . 18.7 m-85 -108.38 130.09 55.23 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.7 p -67.56 150.89 48.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.132 0.492 . . . . 0.0 111.861 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.501 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 4.4 mm? -81.61 36.44 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.106 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.39 -87.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.53 0.732 . . . . 0.0 112.238 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.2 p -138.11 83.12 23.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.942 0.401 . . . . 0.0 110.023 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB3' ' SD ' ' A' ' 111' ' ' MET . 52.3 Cg_exo -57.58 130.33 38.29 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.115 2.544 . . . . 0.0 112.875 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -113.45 149.94 33.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.791 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' GLY . 60.3 m-85 -121.85 111.61 17.32 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.405 0.441 . . . . 0.0 110.359 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -103.33 157.12 17.24 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.499 ' HD2' HG21 ' A' ' 102' ' ' THR . 0.1 OUTLIER -162.19 -176.41 5.12 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.752 -177.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.493 ' HB ' HG13 ' A' ' 106' ' ' VAL . 19.1 mm -86.68 106.47 10.65 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 87' ' ' TYR . 24.9 Cg_exo -63.23 118.48 5.39 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.337 2.024 . . . . 0.0 112.064 -176.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -177.51 -69.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.123 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 93.6 m-20 -135.54 98.73 12.12 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.523 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -88.2 179.47 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.223 2.615 . . . . 0.0 112.68 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 101' ' ' LEU . . . -156.08 173.86 16.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.386 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -85.93 149.6 25.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.688 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.4 mt -75.58 95.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.947 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 92.1 mtp -141.43 -177.32 5.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.199 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 69.66 7.51 6.27 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.75 10.9 58.52 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.768 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.54 ' CD1' ' HG3' ' A' ' 55' ' ' LYS . 26.5 p90 -159.34 -175.66 5.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 0.0 111.138 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.78 130.93 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.541 ' N ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -145.6 151.96 38.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.305 -178.008 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.499 HG21 ' HD2' ' A' ' 87' ' ' TYR . 44.7 p -110.88 -175.2 2.65 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 176.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 3.8 m-20 -89.91 164.98 26.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.69 139.72 83.55 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.187 1.924 . . . . 0.0 112.042 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.94 -12.72 31.98 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.493 HG13 ' HB ' ' A' ' 88' ' ' ILE . 94.7 t -123.93 135.86 62.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.603 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.673 ' CE2' ' HG2' ' A' ' 45' ' ' GLN . 9.7 p90 -142.11 83.75 1.85 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 173.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.421 ' HB2' HG12 ' A' ' 88' ' ' ILE . 47.4 tp60 -167.18 134.66 2.44 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.652 -0.655 . . . . 0.0 110.298 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.407 HD12 HD13 ' A' ' 41' ' ' ILE . 2.2 tm? -144.14 109.0 4.94 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 165.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' PHE . . . -101.76 105.88 2.92 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.578 ' HB3' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -105.53 102.88 12.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.05 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 9.8 pt20 -112.06 121.46 45.04 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.44 0.638 . . . . 0.0 110.733 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 80' ' ' LEU . . . -115.62 -178.5 18.47 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.37 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.8 t -145.48 119.5 9.39 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.565 HG23 ' HB ' ' A' ' 35' ' ' ILE . 6.1 tt -75.55 110.38 10.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 165.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.576 ' HB ' ' HD2' ' A' ' 117' ' ' PRO . 14.1 p -111.59 169.87 5.87 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.829 -168.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 116' ' ' THR . 17.9 Cg_endo -60.5 -2.06 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.164 2.576 . . . . 0.0 112.832 175.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.9 -20.32 66.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.749 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -122.46 123.65 27.0 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.099 174.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.68 122.9 9.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.396 1.398 . . . . 0.0 110.848 174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.685 HD13 ' H ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -75.52 144.48 41.94 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.45 -176.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.663 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 55.4 ttp180 172.47 -42.85 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.716 -173.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 10.8 Cg_endo -54.77 164.81 2.95 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.5 2.133 . . . . 0.0 112.806 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.83 -160.03 16.35 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.059 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.576 HD13 HG21 ' A' ' 153' ' ' THR . 45.7 mt -58.92 144.39 44.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.819 0.342 . . . . 0.0 111.713 -169.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.763 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 23.0 m-85 -99.8 161.34 13.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.471 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -128.76 128.33 43.79 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 151' ' ' THR . 22.2 m -121.49 120.26 61.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.986 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 14.5 p -119.61 134.24 63.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.248 0.547 . . . . 0.0 111.272 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 39' ' ' PHE . 10.0 mt -122.67 140.57 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.089 171.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 57' ' ' TRP . 22.4 m-80 -122.54 148.64 44.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.973 -175.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.575 ' HB1' HE22 ' A' ' 43' ' ' GLN . . . -132.85 144.92 50.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.242 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.94 151.09 21.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 110.81 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.73 129.39 51.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.557 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.48 179.9 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.843 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 25.7 m 79.43 -48.69 0.39 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.521 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -66.23 -52.72 45.02 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.36 -73.61 0.21 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.143 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.413 ' HB2' HG21 ' A' ' 144' ' ' THR . 48.3 m-80 -149.21 155.43 40.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -119.71 74.59 1.02 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -121.12 -74.42 0.61 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -150.23 -56.94 0.18 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.546 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.552 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . . . -134.1 131.68 39.02 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.413 HG21 ' HB2' ' A' ' 139' ' ' ASN . 14.5 t -159.24 -42.87 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.09 -146.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.8 t -79.85 113.96 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.567 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 132' ' ' ALA . . . -96.29 119.27 34.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.321 0.582 . . . . 0.0 110.076 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 131' ' ' ASN . 16.4 ttmm -95.0 155.12 16.86 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.07 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.1 p -136.97 137.91 40.0 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 120.897 0.38 . . . . 0.0 111.983 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 129' ' ' VAL . . . -146.51 121.67 10.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.81 170.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 128' ' ' VAL . 28.2 m -124.09 135.07 53.29 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.489 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.712 ' OG ' ' HB ' ' A' ' 23' ' ' THR . 4.1 m -130.42 135.82 48.4 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.69 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 3.8 m -94.91 125.59 39.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.357 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.427 HG13 ' HG2' ' A' ' 25' ' ' ARG . 1.8 mp -106.82 124.28 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.43 ' HA ' ' CD2' ' A' ' 125' ' ' LEU . 10.0 m -88.31 105.53 17.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.306 0.574 . . . . 0.0 111.67 -175.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.763 HG11 ' CZ ' ' A' ' 126' ' ' TYR . 5.8 p -108.26 129.69 62.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.877 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 30' ' ' ASP . 15.9 m . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.17 -174.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.679 0.276 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.31 53.8 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.358 0.599 . . . . 0.0 112.22 -176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 61.1 m -131.57 132.13 43.86 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.46 173.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -131.88 128.0 37.69 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 120.982 0.42 . . . . 0.0 110.466 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 1.2 mp -136.69 126.85 39.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 m -162.53 139.65 8.0 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.522 0.677 . . . . 0.0 112.139 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.745 ' HA ' ' O ' ' A' ' 40' ' ' THR . 6.4 mt -113.89 109.14 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.238 170.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.493 ' HB ' ' CD ' ' A' ' 21' ' ' PRO . 20.6 p -74.81 166.0 49.09 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -153.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.493 ' CD ' ' HB ' ' A' ' 20' ' ' THR . 47.7 Cg_exo -58.77 -12.92 16.05 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 125.174 3.916 . . . . 0.0 116.579 -167.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.26 -6.97 11.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.822 0.737 . . . . 0.0 110.437 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.712 ' HB ' ' OG ' ' A' ' 152' ' ' SER . 0.6 OUTLIER -62.53 140.1 58.62 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.889 171.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' N ' ' HB3' ' A' ' 152' ' ' SER . 3.5 t30 71.08 150.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.746 176.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 4.1 mmp_? -112.87 -174.79 2.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.519 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.08 -110.22 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.62 -172.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.2 t -90.58 -58.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.134 0.492 . . . . 0.0 110.301 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -168.53 151.95 5.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.816 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.89 134.43 60.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.294 0.569 . . . . 0.0 110.971 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 157' ' ' VAL . 8.1 p-10 -124.39 27.42 7.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.681 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HG3' HD11 ' A' ' 35' ' ' ILE . 9.2 ptp180 -103.49 131.72 50.36 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.148 -176.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 p -98.4 88.47 4.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 166.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.435 ' C ' ' HD3' ' A' ' 117' ' ' PRO . . . -159.69 173.29 16.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.008 -174.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -71.36 111.5 6.73 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.695 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.565 ' HB ' HG23 ' A' ' 115' ' ' ILE . 4.3 mt -115.51 87.32 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -75.19 126.27 30.68 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.772 0.796 . . . . 0.0 110.605 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.1 mt -123.92 108.9 12.93 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.372 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 16.4 m -99.15 109.68 22.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.24 0.543 . . . . 0.0 111.139 -174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB3' HD12 ' A' ' 130' ' ' LEU . 75.7 m-85 -101.25 159.94 14.83 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.745 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 96.1 m -148.7 144.18 26.95 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.143 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD13 HD12 ' A' ' 109' ' ' LEU . 3.6 mp -123.89 124.2 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' ILE . 59.4 mtp180 -111.92 145.99 38.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.575 HE22 ' HB1' ' A' ' 132' ' ' ALA . 2.3 mp0 -123.62 167.47 14.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.427 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' HG3' ' A' ' 43' ' ' GLN . 19.8 Cg_endo -55.44 123.31 13.5 Favored 'Trans proline' 0 N--CA 1.472 0.219 0 C-N-CA 123.75 2.967 . . . . 0.0 114.033 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.673 ' HG2' ' CE2' ' A' ' 107' ' ' TYR . 18.6 mt-30 -62.39 -46.94 86.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.067 177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -76.7 -32.13 57.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.332 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 44' ' ' PRO . 18.9 m -73.3 -40.35 64.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.37 84.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.14 0.495 . . . . 0.0 109.789 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -73.58 -10.6 59.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.108 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.97 -8.5 54.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.975 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.19 16.36 11.37 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.305 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 11.9 mmt -105.78 151.12 24.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.441 ' HD3' HD23 ' A' ' 101' ' ' LEU . 59.4 mtt180 -98.14 156.62 16.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.298 0.57 . . . . 0.0 111.17 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.11 139.16 18.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.491 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.611 ' HD2' ' CZ3' ' A' ' 57' ' ' TRP . 28.3 ttmt -118.36 130.39 55.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.794 175.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.02 140.51 24.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.723 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.611 ' CZ3' ' HD2' ' A' ' 55' ' ' LYS . 6.6 p90 -158.86 161.39 36.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.913 0.387 . . . . 0.0 110.645 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.5 -133.16 3.22 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.265 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 19.1 tt0 -130.46 7.03 4.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -171.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.58 ' HB3' ' H ' ' A' ' 64' ' ' GLN . . . -62.4 177.25 0.52 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 121.332 -0.147 . . . . 0.0 111.137 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -56.98 -30.81 64.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.173 0.511 . . . . 0.0 110.078 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -100.48 12.05 38.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.471 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.52 43.44 77.21 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.58 ' H ' ' HB3' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -108.63 -40.04 5.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -173.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.578 HD22 ' HB3' ' A' ' 111' ' ' MET . 65.8 tp 165.57 126.98 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 46.1 tp -152.15 143.27 23.18 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.832 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.402 ' O ' HG23 ' A' ' 67' ' ' ILE . 16.7 tt -106.22 111.42 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.946 0.879 . . . . 0.0 109.43 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.06 143.55 44.55 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.863 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -47.25 133.45 19.44 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 124.33 3.353 . . . . 0.0 113.203 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -58.46 123.05 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.343 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.39 -0.94 87.33 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.901 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.12 -176.79 31.84 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.553 -0.356 . . . . 0.0 112.236 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -103.5 143.5 32.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.112 0.482 . . . . 0.0 110.492 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.422 ' H ' ' HD3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -60.28 -27.13 67.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.663 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.2 m -74.01 -12.81 60.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.933 0.397 . . . . 0.0 110.793 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.93 -5.39 19.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.257 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.08 173.91 34.61 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.093 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.517 ' CD1' HG13 ' A' ' 119' ' ' ILE . 18.7 m-85 -108.38 130.09 55.23 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.7 p -67.56 150.89 48.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.132 0.492 . . . . 0.0 111.861 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.501 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 4.4 mm? -81.61 36.44 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.106 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.39 -87.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.53 0.732 . . . . 0.0 112.238 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.2 p -138.11 83.12 23.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.942 0.401 . . . . 0.0 110.023 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB3' ' SD ' ' A' ' 111' ' ' MET . 52.3 Cg_exo -57.58 130.33 38.29 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.115 2.544 . . . . 0.0 112.875 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -113.45 149.94 33.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.791 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' GLY . 60.3 m-85 -121.85 111.61 17.32 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.405 0.441 . . . . 0.0 110.359 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -103.33 157.12 17.24 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.499 ' HD2' HG21 ' A' ' 102' ' ' THR . 0.1 OUTLIER -162.19 -176.41 5.12 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.752 -177.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.493 ' HB ' HG13 ' A' ' 106' ' ' VAL . 19.1 mm -86.68 106.47 10.65 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 87' ' ' TYR . 24.9 Cg_exo -63.23 118.48 5.39 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.337 2.024 . . . . 0.0 112.064 -176.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -177.51 -69.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.123 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 93.6 m-20 -135.54 98.73 12.12 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.523 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -88.2 179.47 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.223 2.615 . . . . 0.0 112.68 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 101' ' ' LEU . . . -156.08 173.86 16.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.386 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -85.93 149.6 25.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.688 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.4 mt -75.58 95.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.947 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 92.1 mtp -141.43 -177.32 5.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.199 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 69.66 7.51 6.27 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.75 10.9 58.52 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.768 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.54 ' CD1' ' HG3' ' A' ' 55' ' ' LYS . 26.5 p90 -159.34 -175.66 5.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 0.0 111.138 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.78 130.93 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -145.6 151.96 38.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.305 -178.008 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.499 HG21 ' HD2' ' A' ' 87' ' ' TYR . 44.7 p -110.88 -175.2 2.65 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 176.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 3.8 m-20 -89.91 164.98 26.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.69 139.72 83.55 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.187 1.924 . . . . 0.0 112.042 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.94 -12.72 31.98 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.493 HG13 ' HB ' ' A' ' 88' ' ' ILE . 94.7 t -123.93 135.86 62.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.603 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.673 ' CE2' ' HG2' ' A' ' 45' ' ' GLN . 9.7 p90 -142.11 83.75 1.85 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 173.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.421 ' HB2' HG12 ' A' ' 88' ' ' ILE . 7.4 tp-100 -167.18 134.66 2.44 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.652 -0.655 . . . . 0.0 110.298 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.407 HD12 HD13 ' A' ' 41' ' ' ILE . 2.2 tm? -144.14 109.0 4.94 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 165.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' PHE . . . -101.76 105.88 2.92 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.578 ' HB3' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -105.53 102.88 12.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 9.8 pt20 -112.06 121.46 45.04 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.44 0.638 . . . . 0.0 110.733 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 80' ' ' LEU . . . -115.62 -178.5 18.47 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.37 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.8 t -145.48 119.5 9.39 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.565 HG23 ' HB ' ' A' ' 35' ' ' ILE . 6.1 tt -75.55 110.38 10.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 165.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.576 ' HB ' ' HD2' ' A' ' 117' ' ' PRO . 14.1 p -111.59 169.87 5.87 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.829 -168.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 116' ' ' THR . 17.9 Cg_endo -60.5 -2.06 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.164 2.576 . . . . 0.0 112.832 175.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.9 -20.32 66.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.749 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -122.46 123.65 27.0 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.099 174.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.68 122.9 9.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.396 1.398 . . . . 0.0 110.848 174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.685 ' H ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -75.52 144.48 41.94 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.45 -176.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.663 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 55.4 ttp180 172.47 -42.85 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.716 -173.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HD2' ' N ' ' A' ' 122' ' ' ARG . 10.8 Cg_endo -54.77 164.81 2.95 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.5 2.133 . . . . 0.0 112.806 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.83 -160.03 16.35 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.059 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.576 HD13 HG21 ' A' ' 153' ' ' THR . 45.7 mt -58.92 144.39 44.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.819 0.342 . . . . 0.0 111.713 -169.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.763 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 23.0 m-85 -99.8 161.34 13.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.471 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -128.76 128.33 43.79 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 151' ' ' THR . 22.2 m -121.49 120.26 61.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.986 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 14.5 p -119.61 134.24 63.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.248 0.547 . . . . 0.0 111.272 -177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 39' ' ' PHE . 10.0 mt -122.67 140.57 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.089 171.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.521 ' ND2' HG22 ' A' ' 149' ' ' THR . 13.9 m120 -122.54 148.64 44.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.973 -175.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.575 ' HB1' HE22 ' A' ' 43' ' ' GLN . . . -132.85 144.92 50.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.242 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.94 151.09 21.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 110.81 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.73 129.39 51.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.557 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.48 179.9 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.843 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 25.7 m 79.43 -48.69 0.39 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.521 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -66.23 -52.72 45.02 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.36 -73.61 0.21 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.143 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.413 ' HB2' HG21 ' A' ' 144' ' ' THR . 48.3 m-80 -149.21 155.43 40.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -119.71 74.59 1.02 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -121.12 -74.42 0.61 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -150.23 -56.94 0.18 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.546 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.552 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . . . -134.1 131.68 39.02 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.413 HG21 ' HB2' ' A' ' 139' ' ' ASN . 14.5 t -159.24 -42.87 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.09 -146.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.8 t -79.85 113.96 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.567 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 132' ' ' ALA . . . -96.29 119.27 34.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.321 0.582 . . . . 0.0 110.076 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 131' ' ' ASN . 16.4 ttmm -95.0 155.12 16.86 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.07 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.521 HG22 ' ND2' ' A' ' 131' ' ' ASN . 12.1 p -136.97 137.91 40.0 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 120.897 0.38 . . . . 0.0 111.983 -175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 129' ' ' VAL . . . -146.51 121.67 10.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.81 170.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 128' ' ' VAL . 28.2 m -124.09 135.07 53.29 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.489 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.712 ' OG ' ' HB ' ' A' ' 23' ' ' THR . 4.1 m -130.42 135.82 48.4 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.69 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 3.8 m -94.91 125.59 39.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.357 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.427 HG13 ' HG2' ' A' ' 25' ' ' ARG . 1.8 mp -106.82 124.28 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.43 ' HA ' ' CD2' ' A' ' 125' ' ' LEU . 10.0 m -88.31 105.53 17.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.306 0.574 . . . . 0.0 111.67 -175.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.763 HG11 ' CZ ' ' A' ' 126' ' ' TYR . 5.8 p -108.26 129.69 62.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.877 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 30' ' ' ASP . 15.9 m . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.17 -174.499 . . . . . . . . 1 1 . 1 stop_ save_